Pro-innovation civil society groups gather in New York to talk global health

The debate around innovation and health has been monopolised over the last decade by civil society groups that claim the current system of drug development, underpinned by markets and intellectual property rights, does not function and must be replaced by alternative systems that envisage a far greater role for government. In reality, there is no […]